Pathology Residency Program at Mount Sinai
Mount Sinai Medical Center is home to more of New York’s “Top Doctors” than any other hospital facility in the area. In addition, Icahn School of Medicine has the fastest-growing medical research program in New York with $156 million in NIH grants, according to the most recent data.
The Lillian and Henry M. Stratton-Hans Popper Department of Pathology offers world-class anatomic, clinical, and molecular pathology training programs and a specimen volume nearly three times that of any other medical institution in the region, including rare and esoteric specimens. With a vast array of rotations (8 in both anatomic pathology and clinical pathology plus an additional 8 elective rotations) and multiple hospital rotations serving diverse populations in the region as well as a mandatory rotation to the New York City Medical Examiner’s Office, we provide unmatched training in research and diagnostic pathology and access to the country’s most interesting, complex cases.
About the Chairman of Pathology
In April of this year, Carlos Cordon-Cardo, MD, PhD was appointed Chair of the Department of Pathology at Mount Sinai. A prolific publisher and leader in oncologic pathology, Dr. Cordon-Cardo is internationally recognized as a founding father of molecular pathology and a visionary in the nascent field of systems pathology—a field that uses systems biology to form mathematical models of the interaction and behavior of cancer cells with the goal of determining tumor pathogenesis and clinical outcome.
During his tenure at Mount Sinai, Dr. Cordon-Cardo has already expanded the Department to include mathematicians, computational biologists, and systems biologists in order to integrate advances in molecular medicine and pathology and identify specific biological targets of disease. Ultimately, our goal is to translate those findings into tangible deliverables for export into the clinic.
Fully Integrated Department and Multidisciplinary Approach
The Department of Pathology is on track to become one of the first in the nation to concatenate all pathology departments (clinical, anatomical, molecular, systems, experimental) under a single umbrella. Such a fully integrated pathology department will not only produce a more rationalized approach to pathology and the dissemination of information but will produce far more robust, rounded pathologists who will be uniquely prepared to enter the 21st century paradigm of fully integrated medicine where coordination of care will be an outcome metric of patient-centered medical care.
Mount Sinai also boasts the nation’s second largest bio bank of annotated specimen samples, which makes us a particularly attractive partner to biotech/pharma concerns for translation research and ultimately product development.
Our team is committed to the evolution of pathology from a reactive, after-the-fact diagnostic to a predictive/ preventative science. We have appointed a Vice Chair to head up our molecular/genetics pathology division as we build a stronger bridge between our experimental pathologists and our molecular pathologists.
Our massive tissue banking program allows for a linear progression of study of our patient population with the goal of advancing pathology as an engine for translational research. Edging pathology towards a more precise, personalized medical approach via service integration, risk prediction and pharmacogenomics is our vision of the future and we hope you’ll consider joining us on that journey.
Please email email@example.com for more detailed information about our Pathology Residency Program and benefits.